PeptideDB

Bromo-PEG1-acid 1393330-33-0

Bromo-PEG1-acid 1393330-33-0

CAS No.: 1393330-33-0

Bromo-PEG1-acid is a PEG-based PROTAC (PROteolysis TArgeting Chimera) linker that may be utilized to prepare PROTAC.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bromo-PEG1-acid is a PEG-based PROTAC (PROteolysis TArgeting Chimera) linker that may be utilized to prepare PROTAC.

Physicochemical Properties


Molecular Formula C5H9BRO3
Molecular Weight 197.027161359787
Exact Mass 195.973
CAS # 1393330-33-0
PubChem CID 60146230
Appearance Colorless to light yellow liquid(Density:1.573±0.06 g/cm3)
Density 1.6±0.1 g/cm3
Boiling Point 301.7±22.0 °C at 760 mmHg
Flash Point 136.2±22.3 °C
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.491
LogP 0.7
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 5
Heavy Atom Count 9
Complexity 84.3
Defined Atom Stereocenter Count 0
SMILES

BrCCOCCC(=O)O

InChi Key REBYHCQUFPLTTH-UHFFFAOYSA-N
InChi Code

InChI=1S/C5H9BrO3/c6-2-4-9-3-1-5(7)8/h1-4H2,(H,7,8)
Chemical Name

3-(2-bromoethoxy)propanoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity



Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~507.54 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (12.69 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (12.69 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (12.69 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.0754 mL 25.3768 mL 50.7537 mL
5 mM 1.0151 mL 5.0754 mL 10.1507 mL
10 mM 0.5075 mL 2.5377 mL 5.0754 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.